Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Competing interests: I have read the journal's policy and have the following conflicts: MKE is named as an inventor on patents related to cloning of the Norwalk virus genome and has served as a consultant to Takeda Vaccines, Inc. RLA has received research grant funding from and is an unpaid con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS pathogens 2016-04, Vol.12 (4), p.e1005334-e1005334
Hauptverfasser: Ramani, Sasirekha, Estes, Mary K, Atmar, Robert L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Competing interests: I have read the journal's policy and have the following conflicts: MKE is named as an inventor on patents related to cloning of the Norwalk virus genome and has served as a consultant to Takeda Vaccines, Inc. RLA has received research grant funding from and is an unpaid consultant to Takeda Vaccines, Inc. This does not alter our adherence to all PLOS policies on sharing data and materials. The epidemiology of NoV is complex, with more than 30 genotypes known to cause infections in humans [8]. Since HBGA specificity varies among different NoV genotypes, it is likely that most persons will be susceptible to at least some genotypes [9].
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1005334